Literature DB >> 3885203

Metoprolol in the aged hypertensive: a comparison of two dosage schedules.

A Martin, R C Browning.   

Abstract

Thirty-one patients aged 65 y or over suffering from moderate hypertension were studied for 16 weeks using a cross-over design in which metoprolol 100 mg daily and metoprolol 200 mg daily were compared. Both treatment regimes were effective in controlling hypertension and no difference was found between the two with regard to efficacy. The 100 mg regime was, however, better tolerated and we propose this as the preferred metoprolol dose for the aged hypertensive.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3885203      PMCID: PMC2418180          DOI: 10.1136/pgmj.61.713.225

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS.

Authors:  J E GRIZZLE
Journal:  Biometrics       Date:  1965-06       Impact factor: 2.571

2.  Plasma metoprolol concentrations in young, old and hypertensive subjects.

Authors:  M J Kendall; D Brown; R A Yates
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

3.  Reduced beta-adrenoceptor sensitivity in the elderly.

Authors:  R E Vestal; A J Wood; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

4.  Evaluation of cardiovascular risk in the elderly: the Framingham study.

Authors:  W B Kannel; T Gordan
Journal:  Bull N Y Acad Med       Date:  1978-06

Review 5.  Drug use in the elderly: a review of problems and special considerations.

Authors:  R E Vestal
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

Review 6.  Role of blood pressure in cardiovascular morbidity and mortality.

Authors:  W B Kannel
Journal:  Prog Cardiovasc Dis       Date:  1974 Jul-Aug       Impact factor: 8.194

Review 7.  Drug therapy: Management of hypertension in the elderly.

Authors:  J Koch-Weser; K O'Malley; E O'Brien
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

  7 in total
  2 in total

Review 1.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

Review 2.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.